Abstract: Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Abstract: An inflation valve includes a main valve body having an outlet port, a rupture port, and a pull cord retainer. A puncture retainer body secures a puncture disc within the main valve body to seal the outlet port to gas flow. A slot in the puncture retaining body permits gas flow to the outlet port. A puncture pin received within the puncture retaining body includes a center bore permitting gas flow to the outlet port. A rupture disc breaks under high pressure conditions to permit pressurized gas to exit the rupture port. The rupture disc and puncture disc are interchangeable. A release assembly associated with the pull cord retainer permits manual release of the puncture pin. A vacuum washer is sealed between a vacuum retainer and the pull cord retainer to prevent gas from exiting the pull cord retainer when the inflation valve is activated under vacuum.

Abstract: The present invention provides improving health in a woman or man comprising non-orally administering a testosterone-containing moiety to said woman or man by topically applying a liquid composition including said testosterone-containing moiety to the eye of said woman or man in an amount sufficient to provide a therapeutic effect.

Abstract: An inflation valve includes a main valve body having an outlet port, a rupture port, and a pull cord retainer. A puncture retainer body secures a puncture disc within the main valve body to seal the outlet port to gas flow. A slot in the puncture retaining body permits gas flow to the outlet port. A puncture pin received within the puncture retaining body includes a center bore permitting gas flow to the outlet port. A rupture disc breaks under high pressure conditions to permit pressurized gas to exit the rupture port. The rupture disc and puncture disc are interchangeable. A release assembly associated with the pull cord retainer permits manual release of the puncture pin. A vacuum washer is sealed between a vacuum retainer and the pull cord retainer to prevent gas from exiting the pull cord retainer when the inflation valve is activated under vacuum.